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        This thesis describes phytochemical studies on the methanolic extract of Curcuma longa; a 
medicinally important plant used as indigenous medicine for the treatment of wounds in South 
Asian and African countries. The crude extract displayed antibacterial activity against the Gram-
positive bacterium, Staphylococcus aureus, but was inactive against Gram-positive bacterium 
Streptococcus agalactiae. This extract also did not show antibacterial activity against Gram-
negative bacteria, Escherichia coli and Pseudomonas aeruginosa. Based on the observed 
antibacterial activity, it was decided to carry out phytochemical investigation of crude 
methanolic extract of C. longa to isolate and characterize natural products and evaluate them for 
antimicrobial activity. These efforts resulted in the identification of three known natural 
products: curcumin (39) sclareolide (40) and atalantoflavone (41). Structures of these compounds 
were established with the aid of NMR spectroscopic studies. Compounds (40) and (41) have 
been isolated for the first time from this plant. Compounds (39-41) were found to be inactive 
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Proton Nuclear Magnetic Resonance: Shows the electronic 
environment of proton atom in a molecule. 
13C-NMR 
spectrum 
Carbon Nuclear Magnetic Resonance: Shows the electronic 
environment of carbon atoms in a molecule. 
COSY 
spectrum 
¹H-¹H Correlation Spectroscopy (COSY): Shows the 
correlation between hydrogens which are coupled to each other 
in the ¹H NMR spectrum 
DEPT 
spectrum 
Distortionless Enhancement by Polarization Transfer: Helps to 









Attached Proton Test: Used to differentiate between methyl, 
methylene, and quaternary carbons. 
Heteronuclear Single Quantum Coherence: Shows which 
hydrogens are directly attached to which carbon atoms 
Heteronuclear Multiple Bond Correlation: shows the 







Natural products chemistry 
1.1 Introduction  
 
    Natural products (NPs) are organic chemical substances that are produced from living 
organisms [1]. They can be produced by partial or full chemical synthesis. The source of NPs are 
animal and plant cells, and the secretions of microorganisms. Since ancient times, natural 
products have been widely used for the medical treatment of human and domestic animal 
diseases. Many researchers all over the world are investigating different samples to analyze and 
examine effectivness in drug discovery by bioassays [2,4]. Researchers are currently conducting 
multiple experiments with plants and organisms to explore what biological activity they present 
[5, 6]. NPs and medicine have been closely associated using typical medicines and toxins for 
thousands of years [7,8]. For example, many modern drugs for cardiovascular, cancer, malaria 
and mental health diseases are made from medicinal plants. These drugs come from different 
parts of medicinal plants such as leaves, seeds, fruits and sometimes the whole plant [1].  
    Metabolism is divided into two types: primary and secondary. Primary metabolites are 
considered to be the building blocks of life, so they are necessary for survival. However, 
secondary metabolites are not always important for growth, instead, they have important roles in 
protecting themselves against herbivores and microorganisms. Secondary metabolites are signal 
compounds that attract pollinating and seed dispersing animals or the can function as agents of 
symbiosis between germs, plants, insects, and animals [1]. Natural products are known as 
secondary metabolites and are derived from organisms such as plants, animals, insects, marine 
organisms and microorganisms [1].    
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  A primary metabolite is directly involved in the growth, development, photosynthesis, 
respiration or reproduction of a plant. Plants produce primary metabolites to drive their primary 
life function involving development and growth, respiration, cell differentiation, and internal 
storage of the plant. Primary metabolites vitamins, amino acids, nucleosides, and organic acids 
that are essential for microbial growth during the logarithmic process. Products like alkaloids, 
steroids, antibiotics, gibberellins, and toxins are secondary metabolites. These are produced in 
the stationary phase of microorganism growth and play a vital role in ecological functions [76]. 
The biosynthesis of secondary metabolites comes from the essential processes of photosynthesis, 
glycolysis, and the Krebs cycle to deliver intermediate biosynthesis, which results in the 
formation of secondary metabolites, also called natural products [10].  
    The most important building blocks associated with biosynthesis of secondary metabolites are 
derived from the intermediates, acetyl-CoA, shikimic acid, amino acids, and phenylalanine. The 
main classes of secondary metabolites are alkaloids, polyketides, fatty acids, and 
phenylpropanoids. Modern organic chemistry started with the extraction and the characterization 
of definite substances from plants and animal tissue. In the second half of the 19th century, 
discoveries of new metabolites were rapidly increasing. Organic chemists called these unknown 
metabolites “natural products”. These compounds have many challenges in structure 
determination and overall synthesis [77]. A few examples of primary and secondary metabolites 



















Alcohol Ethanol Pigments Carotenoids, Anthocyanins 
Amino acids Glutamic acid, Aspartic 
acid 
Alkaloids Morphine, Codeine, etc 
Organic acids Acetic acid, Lactic acid Toxins Abrin, Ricin 
Polyols Glycerol Drugs Vinblastin, Curcumin 




1-2 Classification of natural product: 
    Metabolites are naturally abundant with various types of biological activity and present great 
value as bioactive natural products. NPs can contribute to meditation of many diseases [20]. In 
living organisms, primary metabolites are produced in larger quantities than secondary 
metabolites. Although there are no clear functions of every type of secondary metabolites, they 
are potential sources of new antibiotics with fewer side effects. Natural products can be used as 
dyes, fibers, glues, oils, waxes, flavoring agents, and perfumes. Recently, secondary metabolites 
have become widely used in human nutrition research since using natural food has long benefited 
prevention of cancer and several diseases [21]. NPs provide sugar, flavour, color, and promising 






1.2.1 Phenols  
     Phenols are cyclic compounds and are the largest group of secondary plant metabolites. 
Phenols contain an aromatic ring with an –OH (hydroxyl) functional group.  Many plant phenols 
contain the phenyl (C3) - propane radical (C6) [12]. From a chemical standpoint, phenols are 
acidic and more robustly reactive than alcohols. There are a couple of pathways of phenol 
synthesis: the first one is condensation of acetic acid molecules; another is the metabolism of 
phosphorylated sugar. Shown below are a few simple phenol structures: eugenol (1), thymol (2), 
linalool (3), and carvacrol (4), listed in Table 1-2 [13]. Eugenol is found in essential oils of 
clove, cinnamon leaf, pimento leaf, and rose. It is a little spicy and has a pungent odor. Thymol 
and carvacrol are also found in essential oils of thyme, sage, and oregano. Thymol has an 













Table 1-2: Examples of phenol structures (1-4) 
 













                       
 







































1.2.2 Alkaloids  
 
    The structures of all alkaloids contain nitrogen and possess the ability to interact with other 
complex structures via the nitrogen. For many years, alkaloids have been used in medicine as 
common drugs. There are many active compounds extracted from plants that contain oxygen 
with nitrogen in the tertiary position, though some secondary and quaternary types are known. 
Some alkaloids activate the central nervous system as cathinone (5), caffeine (6), nicotine (7), 
quinine (8), listed in Table 1-3 and some inole alkalodis act as psychoactive agents, which cause 
hallucinations. Morphine isolated from Opium became the first pure naturally extracted 
medicine. It is a strong painkiller that is still used in the clinic [23]. Strychnine (9), the crystalline 














Table 1-3: Examples of some alkaloid structures (5-9) 
 




Cathinone (5) [23] 
 
 

































1.2.3 Polyketides    
    Polyketides are one class of natural products that have alternating carbonyl and methylene 
groups (-CO-CH2-). Some Polyketides have antimicrobial activity (e.g., tetracycline) (10) and 
can reduce the activation of the immune system (e.g., rapamycin). They also have many different 
activities such as antifungal (e.g., amphotericin B), antiviral (e.g., balticolid), cholesterol-
reducing (e.g., lovastatin), anti-inflammatory activity (e.g., flavonoids), antifungal (e.g., 
amphotericin B), anticancer (e.g., doxorubicin) (11), and immune suppressing (e.g., rapamycin) 
Table 1-4 [28]. 
    Toxic substances produced by fungi are often polyketides. The biosynthesis of polyketides 
starts with condensing of the starting unit (acetyl-CoA or propionyl-CoA) with an extender unit 
(malonyl-CoA or methylmalonyl-CoA), then processed by decarboxylation of the extender unit. 
Polyketides have many different structures and functions that allow them to have significant 
pharmaceutical and agrochemical potential. Most polyketides are produced by microbes such as 
bacteria and fungi and are found everywhere as they are produced by a host of organisms 
including plants, insects, mollusks, algae, protists, insects, and sponges. Examples of this are: 
bacteria (e.g., tetracycline from Streptomyces aureofaciens), fungi (e.g., lovastatin from 
Phomopsis vexans), plants (e.g., emodin from Rheum palmatum), protists (e.g., maitotoxin-1 
from Gambierdiscus australes), insects (e.g., stegobinone from Stegobium paniceum), and 







Table 1- 4: Examples of some polyketides structures (10-11) 
 





Tetracycline (10) [28] 
 
 






































1.2.4 Terpenoids  
    Terpenoids (isoprenoids), which contain five carbon units, are the biosynthetic precursors of 
different natural compounds. Terpenoids are considered to be the largest class of secondary 
metabolites, which have diverse functionalized hydrocarbons or chiral, carbocyclic skeletons and 
have different substituents or moieties within the molecules such as hydroxyl, carbonyl, ketone, 
aldehydes, and peroxide groups. Terpenoids are responsible for aroma and flavour since they are 
volatile substances in plants and are located in leaves and fruits in some plants such as conifers, 
citrus, and eucalyptus [30]. Terpenoids make up nearly 60 % of all natural products. They have 
several cyclic structures that have oxygen functional groups. Most terpenoids are used for 
chemical reactions and protection in the abiotic and biotic environment. In the past, terpenoids 
were used in food, pharmaceutical, and chemical industries, and most recently in the biofuel 
industry [31]. Even though there is huge chemical diversity, natural products are synthesized 
from a few building blocks such as acetate that has five carbon atoms; mevalonate has five 
carbon atoms, and shikimate that has nine carbon atoms [32]. Terpenoids or isoprenoids be 
modified from ergotamine (12), cannabinol (13), quinine, and vitamin-E. Terpenoids are 
important for every living organism. Cyanobacteria synthesize terpenoids from the 
methylerythritol-phosphate (MEP) pathway and process them by utilizing glyceraldehyde 3-
phosphate and pyruvate produced via the substrates from photosynthesis. The products of MEP 
pathway are isomeric the five-carbon compounds isopentenyl diphosphate and dimethylallyl 





    Terpenes have different numbers of carbons; hemiterpenes contain 5 carbon atoms, 
monoterpenes contain 10 carbon atoms, sesquiterpenes contain 15 carbon atoms, diterpenes 
contain 20 carbon atoms, sesterterpenes contain 25 carbon atoms, triterpenes contain 30 carbon 
atoms, and polyterpenes contain more than 30 carbon atoms [33]. Terpenoids are synthesized 
from the mevalonic acid (MVA) pathway and from the 2C-methyl-D-erythritol-4-phosphate 
(MEP) pathway. Terpenoids have a wide range of roles that have been studied and they have 
been applied as food additives, in perfume making, and as alternative medicines. Terpenes have 
many properties, the most important application of them is the prevention and treatment of 
cancer; paclitaxel (14) and docetaxel (15) are examples of drugs that are used to treat cancer and 
are listed in Table 1-5 [34]. Other important properties of terpenoids are antimicrobial, 
antifungal, antiviral, antihyperglycemic, anti-inflammatory, antioxidant, and antiparasitic 
activities. Since the natural production of terpenoids is limited, synthetic biology and metabolic 











Table 1-5: Examples of some terpenoid structures (12-15) 
 




Ergotamine (12) [34] 
 
 
Cannabinol (13) [34] 
 
 
Paclitaxel (14) [34] 
 
 




















































1.2.5 Phenylpropanoid   
     Phenylpropanoids come from the plant kingdom Apiaceae or Umbelliferae family and they 
are synthesized by plants from the amino acids phenylalanine (16) or tyrosine (17) (Table 1-6). 
Phenylpropanoids are good sources of metabolites in plants that have a cyclic structure that has 
many physiological functions; the enzyme phenylalanine-ammonia lyase (PAL) removes the 
ammonia from l-phenylalanine to produce theses compounds [34]. Phenylpropanoids are 
considered good starting points for making other useful compounds such as coumarins and 
lignans and are used to synthesize ligning, which gives structural support and pathogen 
resistance to plants. Phenylpropanoids play important roles in the making of hydroxycinnamyl 
alcohols and its monolignols are building blocks of lignin. Phenylpropanoids are promising in 
human health with many useful applications. Carrots are important in providing a good source of 
Phenylpropanoids compounds and are reported to have positive affects on our health such as 
epilaserine oxide. Phenylpropanoid compounds such as 2-epilaserine was isolated from carrots 
and reported to be toxic to living cells such as HL-60 cells [35, 36]. Phenylpropanoids contribute 
to biosynthetic reactions to create a large number of compounds such as lignins, flavanols, 
isoflavanoids, anthocyanins, and stilbenes. These compounds have many different functions 
other than plant defense and structural strength. They also have pharmaceutical properties that 







Table 1-6:  The structures of phenylalanine and phenylpropanoids (16-17) 
 
 



































    Aromaticity is the possession of (ring-shaped), planar (flat) structures and a ring of resonance 
bonds which grants increased stability compared with other geometric or conjunctive grouping 
with similar sets of atoms. Aromatic rings are very stable and do not break apart easily. 
Compounds that are derived from benzene (18) are known as aromatic compounds although there 
are some aromatic compounds not derived from benzene found in living organisms such as the 
double-ringed bases in RNA and DNA. The word aromatic was used to describe fragrant 
substance such as benzaldehyde (19) (from cherries, peaches, and almonds), toluene (20) (from 
Tolu balsam), and benzene (from coal distillate). It was found that compounds that have an 
aromatic group behave differently than other organic compounds. Nowadays, the word aromatic 
is used to describe the category of compounds that contain six-membered benzene-like rings that 
have three double bonds. There are numerous natural compounds that are aromatic steroids such 
as estrone (21) and compounds that are used as a medicine such as the cholesterol-lowering 
treatment Lipitor (22) and are listed in Table 1-7. Benzene affects depressed white blood cell 



































































1.2 Importance of Natural Products: 
 
1.3.1 Modern Drug Discovery Process From Terrestrial Plants: 
 
    Natural products are considered a significant source for the discovery of new drugs. 
Throughout history, natural products have played a fundamental role in eliminating harmful 
bacteria and fungi that have threatened human life [43]. Most modern drugs currently used to 
treat medical conditions come from nature since they offer structure diversity and clinical 
specificity. More attention and development should be given to all steps in the development 
process of natural products including collecting the samples, choosing strains, metabolic 
expression, genetic engineering, and isolation of compounds in plants by solvents. Natural 
products could bind by particular interspecific interactions to proteins with similar drug-like 
properties [43]. Cyclosporin A and FK-506 are drugs that come from natural products that work 
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  New technology such as high-throughput screening, combinatorial chemistry, computational 
chemistry, gene chip research, and gene-drug cannot achieve what NPs have provided, Figure 
(1): Sources of compounds for drug discovery [1]. Lead compounds are chemical substances 
which display demanded biological or pharmacological activity. They can lead to the 
development of a new compound for clinical use as lead substances are considered starting 
points in drug design. Drug design methods are used to develop a specific compound’s 
properties. The resulting compounds undergo many studies and become clinical candidates. 
Natural products, synthetics, and combinatorial chemistry are possible sources of lead 








































    Plants play a role in medical treatment to improve our health and well–being, to reduce drug 
costs, and in the bio prospecting for new naturally sourced compounds. Medical plants of interest 
are overused by the pharmaceutical industry and traditional experimenters, which lead to some 
challenges in the collection of desired plants. There is not enough knowledge about the amount 
of harvest, limited legislative and policy guidance, and with some lands having restricted use of 
rights [79]. In fact, it is difficult to meet the needs of the pharmaceutical industry using plants. 
Earth have plants are reaching the point of extinction for the following reasons: 1- desired plants 
are in remote, hard to reach areas; 2- some plant species have disappeared already; 3- by the 17th 
century, humans started to replace the large forest with farms and cities and most plants species 
are found in large forests; 4- plants that have not reached maturity are harvested [80].  
    It is important to start systematic cultivation of plants to provide biodiversity and protect the 
species that are rare or disappearing and find other solutions in order to preserve biodiversity. 
Hundreds of millions of people are still affected by the benefits of collecting medicinal plant and 
animal products, especially in developing countries [81]. Trial and error have provided people 
with the knowledge that they need to develop alternative medicine, which is transferred from 
generation to generation, and sometimes from country to country. In fact, plants, minerals, 
animals, and fungi were the sources that people relied on throughout history of the study of 
material medica, pharmacy, and pharmacognosy. Around 80 % of the inhabitants of developing 
countries rely on alternative medicines; especially plant sourced natural products for their 
primary health care according to the World Health Organization [50, 81]. Around 25 % of new 
pharmaceutical drugs come from plants or are synthesized analogues. Researchers have 
discovered drugs from medical plants for the treatment of diseases. Plants have many biological 
activities such as antioxidant and antimicrobial properties [50]. 
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    There is no reliable estimated number of medical plants in the world; however, there are 
estimates of the number of species that are used as medicine in the range of 35,000 – 70,000 
worldwide [19]. Choosing a candidate species for examination and investigations would be done 
through long-term use by humans; modern isolation of active compound from plants is safer than 
the investigations of plant species without any previous history. In fact, one pharmaceutical drug 
can be effective for more than one disease [83]. There are many patients that have been cured 
and received the benefits of drugs that were extracted from plants although the medicinal species 
is at risk of extinction. Currently, increasingly large amounts of medicinal plants are grown and 
marketed by France, U.K., Canada, Turkey, and U.S.A. Indians consume around 200 tons yearly 
of these herbs while locally 60 tones are produced. China dominates most of the global markets 
for medical plants; other important consumers are France, Germany, Italy, Japan, Spain, UK, and 











1.3.2 Origin of natural products and drug discovery 
    Plants described in the earliest clay cuneiform tablets from Mesopotamia are still used for the 
treatment of coughs, cold, and inflammation [9]. China has great numbers of medical plants; 
around 12,000 and they grow naturally. Thousands of years ago, Chinese people had to use herbs 
as medicine for many illnesses. In China, the use of alternative treatments, which involve herbs, 
is still highly appreciated. Nowadays, well-known drugs used around the world such as 
ergometrine, santonin, scopolamine, reserpine, vincristine, digoxin, deslanoside, and 
camptothecine are extracted from plants that are grown in China. In addition, there are many 
antibiotics isolated from Chinese medicinal plants, some with antimalarial properties [1, 7]. As 
of now, researchers have only studied a small amount of all the plants in the world, therefore the 
future of drug discovery from plants is promising [8]. 
    Thousands of years ago, extracts from natural products were used as medicine. In the 
beginning of civilization, people had to use specific plants and some microbes to treat sickness 
and injuries [37]. Around 3,000 years ago, the Mayans applied fungi grown on green corn to 
address intestinal diseases [84]. A paleoanthropological study was carried out at the cave site at 
Shanidar, Iraq and it was known that more than 60,000 years ago Neanderthals were aware of the 
value of medicinal plants and their properties. Achillea-type, Centaurea solstitialis, Senecio-type, 
Muscari-type, Ephedra altissima, and Althea-type are examples of flowers, which were 
discovered and had a written description that was found in the cave site at Shanidar [38]. The 
oldest medical records from ancient Mesopotamia in 2600 BC record nearly 1,000 medical 
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plants. By 1550 BC, there were 800 complex prescriptions reported in ancient Egypt [61]. The 
importance of natural products for drugs and health has developed significantly over the past 
several years. In the past, our ancestors commonly used various medical plants to overcome pain 
by eating leaves or by using herbs for healing diseases, infections, and other ailments. Natural 
products play an important role in discovering new drug candidate molecules due to their diverse 
molecular biology and diversity of structures that contribute to development of novel compounds 
[61, 62].  
    Chemists are interested in natural products recently since they are a rich source of compounds 
that are supporting and developing drug discovery. Discovering new drugs promises new 
treatment for many different diseases such as dementia and cancer. Since natural products have 
different biological activities and medicinal potency, different cultures have various approaches 
to the use of plants as treatments. Around 2600 BC, ancient Mesopotamian medical texts 
described 1,000 plants and plant-derived substances such as the oils of Cedrus species (cedar), 
Commiphora myrrha (myrrh), and the juice of the poppy seed, Papaver somniferum. Around 
460–377 BC, the Greek practitioner, Hippocrates of Cos, listed around 400 natural agents in his 
written texts, including the laxative properties of melon juice and the wound healing properties 
of olive oil. Roman physicians contributed to further development with various approaches and 
different plants [61, 63]. Around 40–90 AD, Pedanius Dioscorides gathered De Materia Medica, 
in which he recorded around 600 plants with specific dosages and their effects that led to the 
establishment of pharmacology in Europe. In (129–200 AD), Galen, the Greek physician and 
pharmacist, listed 540 plants and mentioned that a plant can have both useful and harmful 
properties depending on how the plant is used and applied medicinally. Following the Greeks, 
the Orient succeeded in using natural product as treatments. Charaka Samhita, the first medicine 
24	
	
treatise, contained the insights and experiences of Indian Ayurveda, which was recorded around 
900 BC and had 341 plant-derived medicines. The Sushruta Samhita (around 600 BC) was 
interested in surgeries and described 395 medicinal plants and 57 animal-derived products. It is 
common for traditional Chinese medicine to use natural products, which is the most primitive 
Chinese medicine and is still used today [64, 61]. The medicinal book, Wu Shi Er Bing Fang, 
translated treatments for 52 diseases, was gathered around 350 BC and recorded 247 natural 
agents and about 150 drug formulae, including some recommendations, properties and the effects 
of drugs from natural sources. The Orient and the Occident were using natural products 
extensively and continuously without knowing what compounds they possessed until the 
eighteenth and nineteenth centuries [61]. 
 
1.3.3 Natural products usage 
    Over the last few decades, the use of herbal medicinal products has been increasing 
tremendously worldwide with more than 80% of the people depending on them and using them 
as primary healthcare, especially in developing countries [14,15,16]. The consumption of 
medicinal plants is increasing because of self-medication by patients or individuals. In addition, 
herbal medicine has fewer side effects and lower costs than synthetically developed drugs. 
Moreover, there is a fear about the possibility of misdiagnosis and side effects of varying nature 
by modern drugs and medicines. Some examples of medicinal plants are Irish moss or carrageen 
moss, which is the source of a beverage, used to treat colds, sore throat, and tuberculosis [17, 
18]. Alga is used to treat kidney diseases and red alga is used to treat cancer medications [10, 17, 




1.3.4 Drug discovery process: 
    In 2008, Newman reported that more than 60 % of drugs came from natural products directly 
or synthetically such as artemisinin, camptothecin, lovastatin, maytansine, paclitaxel, penicillin, 
reserpine, and silibinin [39]. By 1805, German pharmacist Friedrich Wilhelm Sertürner extracted 
morphine (23) from opium, the first pure form natural product that is now used commercially 
[39, 66]. By 1826, Western pharmaceutical companies started to extract drugs as separate 
compounds instead of using whole plants and chemists began to synthesize compounds with 
known structures instead of extracting them. Figure (2) and Figure (3) show some approved 
drugs and sources of small molecule approved drugs below and the codes used in analyses 




Code    
 
 
Brief definition/year  
B Biological macromolecule, 1997  
N Unaltered natural product, 1997  
NB Botanical drug (defined mixture), 2012 
ND Natural product derivative, 1997 
S Synthetic drug, 1997  
S* Synthetic drug (NP pharmacophore), 1997 
V Vaccine, 2003  
/NM Mimic of natural product, 2003  





                                                                   




























	Figure (3): Source of small molecule approved 











     There are examples of drugs derived from plants that are still used in the clinics [2]. One of 
the oldest drugs currently used is aspirin (24). It is synthesized from salicylic acid, extracted from 
plants by acetylation, and used to reduce fever, relieve pain, and also as an anti-inflammatory 
drug [3]. Another example is procaine (25), an anesthetic that is derived from the active plant 
compound, cocaine. In the 17th century, the Chinese found aconitine crystals from Aconitum 
carmichaeli, which was later, studied in 19th century by German scientists [4]. Some common 
drugs isolated from plants are the pain killer morphine, the antitussive codeine (26) [5], and the 
























Table 1-9 Examples of drugs derived from plants (24-27) 
 
 





Aspirin  (24) [3] 
 
 
Procaine  (25) [4] 
 
 
Codeine (26) [5] 
 
 
























    Some examples of known natural compounds that have been named, extracted, and 
synthesized include; salicin from Salix alba (white willow), emetine from Cephaelis 
ipecacuanha (ipecacuanha), strychnine and brucine from Strychnos nux-vomica (strychnos), 
quinine from Cinchona ledgeriana (cinchona bark), colchicine from Colchicum autumale 
(colchicum), caffeine from Coffea arabica, nicotine from Nicotiana tabacum, atropine from 
Atropa belladonna, and cocaine from Erythroxylum coca. These compounds are still used as 
treatments [67, 39].  
    Discovered in the twentieth century, penicillin is the most famous discovery in antibacterial 
drugs and is extracted from the mold, Penicillium notatum. This compound opened the doors for 
other antibacterial drugs that fight many infections. Synthesis of natural compounds and having 
the exact structures of them leads to modification of these compounds by chemists and 












1.4 Bioassay  
1. 4.1 Anti-microbial assays 
      Antibiotics are commonly used as bactericidal or bacteriostatic treatment or prevention of 
infection. Antimicrobial resistance is rising, leading to more challenges in the treatment against 
bacteria to overcome the infections. Antimicrobial resistance has resulted incorrect empirical 
treatment that delays an effective cure, resulting in the use of less effective, more toxic, and 
further costly drugs. [47]. Antibiotics halt the growth of the cell by inhibiting chemical reactions 
inside the cells, some of which affect metabolic process. Other antibiotics affect the 
polymerization reaction leading to the inhibition of the growth of cells, the result of antibiotics 
[46]. 
The “golden age of Antibiotics'' started in the 1940s and lasted until the 1970s, following the 
discovery of penicillin, accidentally, by Alexander Fleming in 1928 and development by Chain 
and Florey in the 1940s [43]. There are different kinds of microbial natural products such as 
antidiuretic drugs, hormone, antagonists, anticancer drugs, and agricultural and pharmaceutical 
agents [43]. Natural products continuously produce diverse structures that have effective 
antimicrobial activity. Nowadays, there are other approaches to cultivate bacteria to enhance the 
production of new natural products. Natural products are considered as starting points to produce 
new antibacterial compounds. Polymyxins, including polymyxin B and polymyxin E (colistin) 
are considered as antibiotics, which have started to be used globally to treat people who are 





1.4.2 Antimicrobial compounds:  
  Antibiotics play an important role in fighting bacterial infections, however, after discovery they 
faced resistance and its still the efficiency of antibiotics. As a result, there is urgent need to 
resolve infections of bacteria by discovering antibiotics from natural products.  Natural products 
play a significant role in the discovery of antibiotics since 1941, when penicillin was discovered 
and entered the market. Nowadays, natural products are a major source for discovering new 
effective drugs. It is supposed that new drugs from non-natural sources could be more active and 
stronger, yet they have provided disappointing results. The lack of 'privileged structures' of 
synthetic chemistry leads to lower rate of production of discovering drugs. Therefore, microbials 
would have resistance to antibiotics easily. Compounds from natural sources with ‘privileged 
structures’ provide excellent antimicrobial agents [48]. Natural products have been isolated and 
purified for many reasons including treating human infections and diseases. Research tends to 
study activities of secondary metabolites; theses include antimicrobial, antifungal, anticancer, 
and anti-inflammatory activities. Vinca alkaloid is an example of secondary metabolites used in 
cancer chemotherapy. Digitoxin is a second example of a secondary metabolite that is extracted 
from digitalis plant, which cures heart failure. The secondary metabolite, an alkaloid called 
quinine, is extracted from Cinchona tree and is used to heal malaria. Moreover, secondary 
metabolites have other uses besides human medicine such as food preservation and as 
antioxidants. In addition, secondary metabolites kill microorganisms or stop their growth. 
Occasionally antioxidant and antimicrobial properties are found in the same molecule, which 





1.4.3 Recent approaches in natural product research 
    It has been reported that the FDA approved several antibiotics that are all new antibacterial 
agents that have been approved after the year 2000 as shown in Table 1-9A [59]. Natural 
products play important roles in the discovery of antibiotics, of which more than half came from 
natural products. Synthetic routes could not provide leads and natural products proved ability to 
produce drug-like properties [56]. There are many new antimicrobial agents that have been 
marketed recently, Table 1-9B. Natural products are important for life science applications that 
could extract target drugs. The actual sales of marketed drugs are the reflection of the success 
and significance of natural products and the impact of biomechanical tools. Natural products 
contribute to chemical and biological products that are useful products. Products that are in the 
market are either from natural products directly or derived from them, Table 1-10. However, the 
success and approval of the drugs faces many challenges starting from the identification of new 












Table 1-10A: Newer antibacterial agents [59].                             
 
Name of Drug 
 
Class of Drug 






Daptomycin Lipopeptide 2003 Gram+ve bacteria 
Telithromycin Ketolide 2004 Gram+ve and-ve 
Tigecycline Glycylcycline 2005 Gram+ve and-ve 
Doripenem Carbapenems 2007 Gram+ve and+ve 
Retapamulin Pleuromutilin 2007 Gram+ve 
Telavancin Glycopeptides 2009 Gram+ve 
Ceftobiprole Cephalosporin 2010 Gram+ve 













Table 1-10B: Newer antibacterial agents [59].                         
 
Name of Drug 
 
Class of Drug 






Ceftobiprole Cephalosporin Approval awaited Gram+ve 
Iclaprim DHFR inhibitor Approval awaited Gram+ve 
Awaiting FDA Approval 
Torezolid Oxazolidinones Phase II Gram+ve 
Radezolid Oxazolidinones Phase II Gram+ve 
Cethromycin Ketolides Phase III Gram+ve 
Solithromycin Ketolides Phase II Gram+ve 
Oritavancin Glycopepetide Phase III Gram+ve 
Dalbavancin Glycopepetide Phase III Gram+ve 
                                                










1.4.4 Development of antibiotics 
    Antibiotics have been synthesized from either natural products or from synthetic compounds. 
Natural products were the first source for discovering antibiotics from a mold by Alexander 
Fleming in 1928. Drugs can be extracted from soil, bacteria, molds, marine organisms, and 
plants as natural sources for discovering new chemical entities (NCE) and using them in the 
clinic. Most antibiotics that are used around the world come from natural sources. The main 
reason for the urgency of discovering antibiotics is that there is rapidly increasing resistance 
against current drugs [49].  
1.4.5 Drugs resistance 
    Antibiotics were shown to effectively fight infections when used. Nevertheless, in his 1945 
Nobel Prize acceptance speech, Fleming mentioned that the misuse of antibiotics would cause 
resistance. He said ‘there may be danger, though, in under dosage. It is not difficult to make 
microbes resistant to penicillin in the laboratory by exposing them to concentrations not 
sufficient to kill them’ and the same thing has occasionally happened in the body and by 1947, 
there was a huge global antimicrobial resistance. It was reported that 38 patients of 100 people 
were infected with staphylococcal after the staphylococcal became resisted against penicillin.  
[54]. Since resistance to many antibiotics appeared this encouraged the researchers to discover 
new antimicrobial activities. By 1975, there was a new approach to making penicillin 
chemically; a semisynthetic way starting from a lactam ring, 6-aminopenicillanic acids. In 1960 
and 1961, methicillin and ampicillin were synthesized [55]. Discovering new antibiotics is an 
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attempt of resistance. By 1961 resistance to methicillin by a strain of S. aureus was shown. By 
1984, the susceptibility of S.aureus against penicillin decreased from 85% before 1946 to 
between 20% and 30%. Moreover, the report from the Italian Epidemiology Observatory 
reported a total resistance of 14.3% to penicillin [57]. The relationship between using antibiotics 
and increasing the resistance was less by 3% in children than adults. Additionally, in Taiwan by 
1998-2001, it was reported that resistance was 76% in isolates from people who got infected with 
invasive pneumococci. A study was conducted in Iceland to prove the relationship between the 
amount of resistance and the use of antibiotics [26]. It was reported that the resistance to 
penicillin was reduced when the use of it was reduced, however, the rate of resistance to 
macrolides got higher after an increased use of it. By 2003, resistance to penicillin of methicillin 
resistant Staphylococcus aureus (MRSA) from nasal swabs in Korea was 91% and 82.1% in 
Germany. In addition, in Canada, MRSA resistance to fluoroquinolones was 92% and 90% to 
clarithromycin. By 2004, in the US, Jacobs and co-workers published that the susceptibility of 
Streptocuccus pneumoniae to penicillins and clindamycin was 49% [71].  
    The reduction or decrease in effectiveness of medication (e.g., antimicrobial or antineoplastic) 
for the curing of disease is called drug resistance. When an organism is resistant to more than 
one drug it is called multi-drug resistance. Drug resistance generally happens because of misuse   
or overuse of antimicrobials, inappropriate use of antimicrobials, and patient not completing the 
recommended course of treatment. From the last half-century, the number of drug resistant 
people increased worldwide.  Globally, every year, 700,000 die because of drug resistant illness 
[71, 72]. 
    Antimicrobial resistance: It is the ability of a microbe to impede the proper function of 
medication that once could perfectly treat the microbes. Antimicrobial resistance arises due to 
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genetic changes in microorganism (viruses, bacteria, fungi, etc.) that arise during treatment. 
Microorganisms that are resistant to many antibiotics are called “superbugs” [72, 73]. Resistant 
microbes are much more difficult to treat and need alternate or higher doses of antimicrobials. 
  Antineoplastic resistance: This type of resistance is similar to chemotherapy resistance. 
Antineoplastic resistance, usually utilized interchangeably with chemotherapy resistance, is the 
resistance of neoplasm, or the capacity of cancer cells to continue to live and grow through anti-
cancer treatment. Sometimes cancers can develop resistance to many drugs, which is called 
multiple drug resistance. Antineoplastic therapies can fail by two ways; inherent resistance and 
acquired resistance. Inherent resistance is the genetic characteristics that give cancer cells 
resistance from the beginning. Acquired resistance occurs after drug exposure. To reduce drug 
resistance, it is essential to discover alternate chemotherapy agents that have less resistance and 
side effects, such as natural products [74]. 
    The most important attribute of antibacterial drugs is their selectivity of toxicity in only killing 
or inhibiting the growth microbial targets. Each antibacterial drug has an individual mode of 
function. The first discovered antibiotic drug is penicillin. The group of drug compounds 
including penicillins, monobactams, cephalosporins, and carbapenemes are characterized by the 
presence of a β-lactam ring that exists in the central structure of the drug molecules. During the 
biosynthesis of peptidoglycan around the bacterial cell, β-lactams prevent the crosslinking of the 
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Phytochemical investigation of Curcuma longa 
 
2.1   Introduction 
 
    Curcuma longa, commonly known as turmeric, is a perennial herb. This plant belongs to the 
Zingiberaceae (ginger) family and grows to a height of 3 to 5 feet [4]. This plant is abundant in 
countries of tropical climate including Bangladesh, India, Pakistan, Sri Lanka, and other Asian 
countries [5]. It has oblong, pointed leaves and funnel shaped yellow flowers. Its rhizome, in 
boiled, dried, and powdered form, is used as folk medicines to treat various ailments such as 
stomach disorders, inflammation, wounds, joint pain, coughing, diabetes, hepatitis, and anorexia 
[1, 3]. This plant is also used to flavor food in Bangladesh, India, Pakistan, Sri Lanka, and other 
Asian countries. Phytochemical studies on various plants of genus Curcuma have resulted in the 
identification of over 235 different classes of natural products. These phytochemicals include 
diarylheptanoids and diarylpentanoids, phenylpropene, flavanoids, terpenoids, steroids, and 
alkaloids. Previous phytochemical reports on C. longa have shown the presence of terpenoids, 
flavonoids, and curcuminoids and these compounds are assumed to be responsible for the folk 
medicinal applications of this plant [1, 2]. These compounds have been reported to exhibit 
different biological activities. Names and structures of curcuminoids isolated from C. longoa (1-
22) have been listed in Table 2-1 
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     Compounds 4, 6, 7, 10 and 11 showed the cytotoxicity activities against three human cancer 
cell lines, namely, human alveolar adenocarcinoma (A549), human breast cancer (MDA-MB-
231), and human hepatocellular liver carcinoma (HepG2). The bioactivity of these compounds is 
listed in Table 2-2. The bioactivity of these compounds is moderate compared to taxol (18), 
listed in Table 2-2, and are currently used in clinics as an anticancer agent [6]. 
    Phytochemical studies on C. longa have afforded compounds namely, curcumin (15), 
demethoxycurcumin (16), bisdemethoxycurcumin (17), alpha- turmerone (24), and ar-turmerone 
(27). The compounds have been reported to exhibit concentrations producing 50 % growth 
inhibition (IC50) of curcuminoids and turmerones isolated from Curcuma longa on cancer cell 
lines and normal skin fibroblasts (15- 16-17, 24 and 27) Table 2.3. Some of theses compounds 
showed bioactivities and are listed in Table 2-4. Structures of compounds (13−22) from C. longa 












Table 2-1: Names and structures of curcuminoids isolated from C. longoa (1-22) 
 
Name of Compounds 
 
Structures 
       




ether (11) [6] 
Didemethoxybisabolocurcumin 
ether (12)[6]  
 
 









1 R1=OCH3   R2=OCH3   R3=H2  
10 R1=OCH3   R2=OCH3   R3=O
11  R1=H         R2=OCH3   R3=O











Terpecurcumin C (3) [6] 
Terpecurcumin D (4) [6] 
 
 
Terpecurcumin E (5) [6] 
Terpecurcumin F (6) [6] 
Terpecurcumin G (7) [6] 
 
 
Terpecurcumin H (8)[6] 





















5  R1=OCH3    R2=H2
6  R1=OCH3    R2=O









8  R1=OH   R2=H2
9  R1=H     R2=O
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  4′′- (3′′′-methoxy-4′′′-hydroxyphenyl)-
2′′-oxo-3′′-enebutanyl 3-(3′-methoxy-




1,4,6- heptatrien-3-one (14) [10] 
 
- 1,7-bis (4-hydroxy-3-methoxyphenyl)-




dione (demethoxycurcumin) (16) [6,9] 
- 1,7-bis (4-hydroxyphenyl)-1,6-
heptadiene-3, 5-dione 
(bisdemethoxycurcumin) (17) [6,9] 
 
1-hydroxy-1, 7-bis (4-hydroxy-3-




















15 R, R’ = OCH3









1,7-bis (4-hydroxyphenyl)-1-hep- tene-3, 
5-dione (20) [6] 
 
1,7-bis (4-hydroxyphenyl)-1,4,6-
heptatrien-3-one (21) [6] 
 
1,5-bis (4-hydroxy-3-methoxy- phenyl)-































                 Table 2-2: Cytotoxic activity of compounds (1-11 and 15-18) [6]   
      
          Compound  
 
                               Cell lines  
          A549                          HepG2                          MDA-
MB-231  
 
1 30.6 25.0 27.3 
2 61.9 64.1 74.9 
3 35.0 29.5 24.6 
4 14.3 18.3 15.9 
5 41.4 35.9 84.1 
6 15.2 15.7 19.4 
7 14.5 17.1 15.9 
8 84.3 54.6 43.7 
9 41.1 50.3 69.5 
9 16.1 15.4 10.6 
10 16.6 13.0 10.3 
11 27.4 22.7 30.8 
Curcumin (15) 
 








38.1 62.9 38.5 
Taxol (18) 
 








Table 2-3 Concentrations producing 50% growth inhibition (IC50) of curcuminoids and 
turmerones isolated from Curcuma longa on cancer cell lines and normal skin fibroblasts        
(15,16, 17,24 and 27) [9].  
 IC50 (µg /ml)  
 
     HepG2           MCF-7      MDA-MB-231       Hs-68  
Curcumin (15) 15.8 24.8 11.0 >50 
Demethoxycurcumin 
(16) 
18.1 22.1 11.4 >50 
Bisdemethoxycurcumin 
(17) 
19.5 28.2 12.1 >100 
Alpha- turmerone (24) 32.9 41.8 30.2 >100 













Table 2-4 Protection of PC12 cells from ßA Insult by natural products (13-22) isolated from C. 
longa  [10].  
        
         Compounds 
PC12 cells  
Anti-ßA (25-35)  
ED50b (µg/mL) 
PC12 cells  
Anti-ßA (1-42)  
ED50b (µg/mL)  
 
13 1.0  +- 0.3 
 
2.0+-0.4 
14 >50 >50 
15 7.0 +- 1.1 10.0+-0.9 
16 4.0 +- 0.5 5.0+-0.5 
17 2.0+-0.6 3.5+-0.7 
19 30.7+-3.3 44.3+-3.1 
20 0.5+-0.2 1.0+-0.3 
21 >50 >50 
22 >50 >50 








   
  Phytochemical investigation of C. longa also resulted in the identification of terpenoids (24-38), 
and their names and structures are listed in Table 2-5. Some of these terpenoids have shown 
IC50 values in compounds (25-38) inhibiting NO production in BV-2 cells [8], listed in Tables 
2-6. Some of these terpenoids such as alpha- turmerone (24) and ar-turmerone (27) have also 















            
            Table 2-5 Structures of terpenoids (24-38) reported from C. longa.           
 
 











Longpene C (25) [8] 
 
 




Ar-tumerone (27) [8,9] 
 
Turmeronol B (28)[8] 
    
Turmeronol A (29)[8] 
 
 












27 R1 = R2 =H
28 R1 = OH, R2 = H






               
             Bisacurone (31)[8] 
               
 
       Ar-dihydroturmer- one (32)[8] 
                   
            
              Curzerenone (33)[8] 
                  
               
            Curcumenol (34)[8] 
                  
            
          Isocurcumenol (35)[8] 
                
             
             Procurcumenol (36)[8] 
           
                  
              Zedoardiol (37)[8] 
              
             
          Zedoalactone F (38)[8] 
           
 








































25 87.3 32 >100 
26 98.1 33 >100 
27 92.1 34 >100 
28 49.0 35 23.6 
29 >100 36 97.0 
30 30.0 37 37.1 
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    This plant has shown antimicrobial activity and this activity is assumed to be associated with 
the presence of a major metabolite, curcuminoids terpenoids, and other compounds. It was 
decided to carry out antimicrobial activity directed phytochemical studies on the crude 
methanolic extract of this plant in order to identify the antimicrobial natural products to answer 
two questions: (i) to confirm the aforementioned claims or (ii) bioactivity is associated with other 
natural products present in this plant. 
 














2.2. Experimental Section 
2.2.1 General Experimental Conditions 
    Solvents including methanol, ethyl acetate, chloroform, dichloromethane, and hexane used in 
this research for extraction and chromatographic work were of ACS grade and purchased from 
VWR-USA. NMR one-dimensional experiments (1H-, 13C- NMR spectra), and two-dimensional 
NMR experiments (COSY, HSQC, and HMBC spectra) were carried out on a Bruker Avance at 
400MHz NMR spectrometer. These experiments were performed in deuterated chloroform 
(CDCl3) and acetone (C3D3O) which were purchased from Cambridge Isotope Laboratories, Inc. 
USA. Thin layer chromatography (TLC) was performed on silica gel GF254 pre-coated plates 
purchased from SiliCycle, Canada while silica gel (230-400 mesh) was used as the stationary 
phase in the column chromatography and was purchased from Caledon Laboratory Chemicals, 
Canada. TLC plates were also developed using 10% H2SO4.  
2.2.2 Extraction and Isolation: 
    The dried root of C. longa (9 kg) was extracted with methanol (8L; 3 × times) at room 
temperature. The crude extract was filtrated using filter paper and solvent was removed under 
vacuum to afford yellow colored gum (320 g). This extract was then dissolved in a mixture of 
80% methanol (MeOH) and 20% water (H2O) (2 L-80: 20) to make an aqueous methanolic 
extract. The antimicrobial activity was performed on the crude extract against Gram- positive 
and Gram-negative bacteria and the detailed procedure is described on page (29-32). 
    The crude methanolic extract was active against Gram-positive bacteria (Staphylococcus 
aureus and Streptococcus agalactiae) but was inactive against Gram-negative bacteria 
(Escherichia coli and Pseudomonas aeruginosa) and this aqueous-alcoholic extract was defatted 
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with hexane.  Both hexane and defatted extracts were dried using rotatory evaporator. The 
defatted extract (129 g) was found to be bioactive and was loaded onto a column. This column 
was eluted with hexane-chloroform (0-100%) to afford several fractions, which were pooled 
based on the results from analytical TLC data to afford 21 fractions (F1-F21). Antimicrobial 
assay on these fraction revealed that fractions F18 and F20 were bioactive.  Fraction F18 (7.1g), 
was subjected to column chromatography using chloroform-methanol (0-100%) as eluent to 
yield several fractions. All of these fractions were pooled on the basis of analytical TLC. A 
fraction obtained on elution of silica gel column with chloroform-methanol (85%-15%) was 
subjected to analytical TLC using 9% dichloromethane (DCM) and 1% Methanol (MeOH) and 
this showed one major spot along with some minor compounds. The prep-TLC of this fraction 
using the same mobile phase as that of analytical TLC afforded one major compound (180 mg) 
along with minor compounds. The 1H- and 13C-NMR spectra of the major compound were 
acquired and were found to be identical as those of curcumin (F18). The minor compounds were 
not obtained in sufficient quantities to record their 1H and 13C-NMR spectra. Analytical TLC of 
(F20) (95 mg) was performed using chloroform-methanol (98:2) and it revealed the presence of 
two spots. One of these spots was UV active while other was UV inactive. The latter spot along 
with the former was visualized by developing TLC with 10% sulfuric acid. The prep-TLC of this 
fraction using the same mobile phase as that of analytical TLC resulted in the isolation of a white 
coloured compound (F20) (31 mg) and yellow coloured compound (F20) (70 mg). The 1H- and 
13C-NMR spectra of these compounds were found to be identical to those of sclareolide (F20) 





Curcumin (39): brown coloured amorphous solid, (180 mg); 1H-NMR  (acetone-d6, 400 MHz): 
see Table 2-7; 13C-NMR (acetone-d6, 100 MHz):  see Table 2-7. 
Sclareolide (40): white coloured amorphous solid, (31mg). 1H-NMR (acetone-d6, 400 MHz:) see 
Table 2-8; 13C-NMR (acetone-d6, 100 MHz):  see Table 2-8. 
Atalantoflavone (41): yellow coloured gum, (70 mg); 1H-NMR (acetone-d6, 400 MHz): see 
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(9Kg) 	
	
Extract it with 





Extract (129 g)  
Extract it with 3 
x MeoH: H2O 
Dried the crude 
under vacuum 
Hexane: CHcl3 













           The interested fractions  
-Dried+ grounded + added 
silica gel  
-Secondary Column for F18 
- Used Chloroform-methanol 
(0-100%) Yield F1, F2, F3…. F37 
Interested fraction  
F15 (2.3g) 
Major compound;  
Curcumin (33), 
(180 mg)  
 



















Interested fraction  
Scheme 2-1:Summarized isolation procedures 
for pure compounds  															
	
Methanol-DCM 
    1%: 9%	
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2.2.3 Antimicrobial assay 
     Antibacterial activity was determined against cultures of Gram-positive bacteria 
(Staphylococcus aureus and Streptococcus agalactiae) and Gram-negative bacteria (Escherichia 
coli and Pseudomonas aeruginosa). The antimicrobial activity was performed using Kirby- 
Bauer disc method. The stock solution was prepared with different concentrations, which were 
applied onto 6 mm diameter filter-paper disks. A final disc loading concentration of 300 mg/10 
ml for the crude extract and 1 mg/3 ml for the pure compounds was used. The impregnated discs 
were placed on prepared plates with the selected test organisms, along with discs containing a 
disc of negative control that was prepared by loading methanol and ciprofloxacin was used as a 
positive control standard. The plates were incubated at 37 °C for 24 hours and antimicrobial 
activity was recorded as the clear zones of inhibition surrounding the discs. The diameter was 
measured in mm and the experiment was carried out one time. The aseptic condition was applied 











2.2.4 Results and discussion 
    Phytochemical studies on the methanolic extract of C. longa resulted in the isolation of three 
natural products, Curcumin (39), sclareolide (40), and atalantoflavone (41). The detailed 
isolation procedure has been described in section 2.2.1 of this chapter (page 63).  
    Structure of these compounds were elucidated with the aid of NMR spectroscopic studies, 
summarized as follows. 
 2.2.5 Structure Elucidation Compounds (39, 40 and 41) 
2.2.5.1 Curcumin (39) 
 
 
                                  
                                           
    Curcumin (39) was isolated as a brown amorphous solid. The 1H-NMR spectrum (acetone-d6, 
400 MHz) of this compound displayed a three-proton singlet at δ 3.79 due to the O-methyl 
protons substituted at C-3/C-3’. A broad singlet centred at δ 8.20 was ascribed to C-2/C-2’ 
phenolic proton. Resonances at δ 7.64, δ 6.75, δ 7.15, δ 6.94 were due to H-4/H-4’, H-6/H-6’, H-






















resonated at δ 7.37, and δ 6.07, respectively. C4/C-4’, C-6/C-6’, C-7/C-7’and C-8/C-8’ methine 
carbons resonated at δ 140.5, δ 122.9, δ 121.4, and δ 115.3, respectively. 
It showed two one-proton of cis isomerism doublets at δ 7.64 and δ 7.64  (J = 15.0 Hz) and δ 
6.75 and δ 6.75 (J = 15.0 Hz) due to H-4/H-4’ and H-6/H-6’ respectively. Two one-proton 
doublets at δ 7.17 and δ 7.17 (J = 8.0 Hz) and δ 6.94 and δ 6.94 (J = 8.0 Hz) showed sp3 
hybridization of neighbouring protons due to H-7/H-7’ and H-8/H-8’ respectively. 
    The COSY spectrum of Curcumin (39) showed vicinal coupling of H-4/H-4’ (δ 7.64) with H-
6/H-6’ (δ 6.75). Similarly, H-7/H-7’ (δ 7.15) exhibited cross peaks with H-8/H-8’ (δ 6.94).   
     The 13C-APT-NMR spectrum (acetone-d6, 100 MHz) of (39) showed the presence of eleven 
methine, two methyl, and eight quaternary carbons. It also showed twenty-one carbons and the 
complete 13C-NMR chemical shift assignments of (39) are shown in Table 2-7.  
     The HSQC spectrum of (39) was acquired in order to establish 1H/13C one-bond shift 
correlations of all the hydrogen bearing carbons. H-4/H-4’ (δ 7.64) showed cross peaks with C-
4/C-4’ (δ 140.5). H-6/H-6’ (δ 6.74) exhibited 1H/13C one-bond shift correlations with C-1 (δ 
185.0). In addition, the H-8/H-8’ (δ 6.94) showed correlation with C-8/C-8’ (δ 115.3). Complete 
13C-NMR chemical shift values and 1H/13C one-bond shift correlations of all hydrogen bearing 
carbons, as determined from HSQC spectrum, are shown in Table 2-7.  
    The HMBC spectrum of (39) showed long-range couplings of H-7/H-7’ (δ 7.15) with C-9/C-
9’ (δ 110.6).  H–4/H-4’ (δ 7.64) showed other coupling with C-7/C-7’ (δ 121.4). H-9/H-9’ (δ 
7.37) was coupled to C-4/C-4’ (δ 140.5). In addition, H-8/H-8’ (δ 6.94) exhibited coupling with 




Table 2-7 1H and 13C NMR chemical shift assignments of (39) and 1H/13C one-bond shift 
correlations, as determined by HSQC. 
____________________________________________________________________ 
Position                    δH (J in Hz)                     δC (multiplicity†) 
 
1 - 185.0 (C=O) 







4 7.64, d (15.0) 140.5 (-CH-) 
5 - 127.5 (-C-) 
6 6.75, d (15.0) 122.9 (-CH-) 
7 7.15, d (8.0) 121.4 (-CH-) 
8 6.94,d (8.0) 115.3 (-CH-) 
9 7.37,s 110.6 (-CH-) 
10 6,07,s 100.7 (-CH-) 
1’ -       185.0 (-C-OH-) 






 55.4 (-OCH3) 
4’ 7.64,d (15.0) 140.5 (-CH-) 
 5’ -      127.5 (-C-) 
6’ 6.75,d (15.0) 122.9 (-CH-) 
7’ 7.15,d (8.0) 121.45 (-CH-) 
8’ 6.94,d (8.0) 115.3 (-CH-) 
9’ 7.37,s 110.6 (-CH-) 
 




    The 1H- and 13C-NMR spectroscopic data of compound (39) was identical to those of 




















2.2.5.2 Sclareolide (40) 
 
                                                                 
 
    The second compound, sclareolide (40), was isolated as white amorphous solid. Its 1H-NMR 
spectrum (acetone-d6, 400 MHz) showed three three-proton resonances at δ 1.35, δ 0.98, δ 0.88 
and δ 0.91 due to C-13, C-14, C-15, and C-16 methyl protons, respectively. A set of two one-
proton double doublets, resonated at δ 2.56 and δ 2.53, was due to C-11 methylene protons. The 
downfield chemical shift values of these protons were indicative of the presence of germinal 
carbonyl moiety. A one-proton double doublet centered δ 2.10 was ascribed to C-9 methine 
proton. Complete 1H-NMR chemical shift assignments of compound (40) are shown in Table 2-
8. 
  
The COSY- spectrum of compound (40) showed the vicinal couplings of H2-11  (δ 2.56) with H-
9 (δ 2.10). Similarly, 1H-1H vincinal and germinal couplings of other protons in this compound 
were traced from the COSY spectrum that helped in assigning 1H-NMR chemical shift 
























    The 13C-APT-NMR spectrum (acetone-d6, 100 MHz) of (40) showed the signals for all sixteen 
carbons and revealed the presence of four methyl, six methylene, two methine, and four 
quaternary carbons in (40). Complete 1H and 13C-NMR chemical shift assignments of (40) are 
shown in Table 2-8. 
    The 1H and 13C-NMR spectroscopic data of compound (40) was similar to those of sclareolide, 
reported in literature [12]. This compound was previously reported from Arnica angustifolia 
[13]. These spectroscopic data led us to identify compound (40) as sclareolide. Compound (40) 
















Table 2-8 1H and 13C NMR spectroscopic data for (40) and 1H/13C one-bond shift 
correlations. 
         Position                    δH (J in Hz)                     δC (multiplicity†) 
 
1 1.53,1.79,m 39.5 (-CH2-) 
2       1.28,1.29,m 18.8 (-CH2-) 
3 1.53,1.53,m 42.0 (-CH2-) 
4 - 33.3 (-C-) 
5 1.48,dd (11.2,13.6) 56.6 (-CH-) 
6 1.43,1.72 m 20.5 (-CH2-) 
7 1.68,1.69, m 36.2 (-CH2-) 
8 - 85.0 (-C-) 
9 2.10,dd (4.8,7.2) 59.0 (-CH-) 
10 - 37.5 (-C-) 
11 2.56, 2.53,m 32.6 (-CH2-) 
12                  - 175.6 (-C=O-) 
13 1.35,s  21.1(-CH3-) 
 14 0.98,s        14.4 (-CH3-)   
   15 0.88,s       27.8 (-CH3-) 
16 0.91,s 29.3 (-CH3-) 
 









2.2.5.3 Atalantoflavone (41) 
 
 
                                                         
 
     The third compound, atalantoflavone (41), was isolated as yellow amorphous solid. The 1H-
NMR spectrum (acetone-d6, 400 MHz) of (41) showed the resonance of two six proton singlets at 
δ 1.24 due to the C-5’/C-6’ methyl protons. A set of two doublets, integrating for two protons 
each, appeared at δ 7.45 and were assigned to H-2’’/H-6’’and H-3’’/H-5’’, respectively. The 
double set of two one-proton doublets at δ 6.65 and δ 5.70 were due to H-3’ and H-4’ protons, 
respectively. The C-3 methine proton resonated at δ 6.29.  
  It showed two one-proton doublets at δ 6.65 (J = 10.1 Hz) and δ 5.7 (J = 10.1 Hz) due to H-3’ 
and H-4’ respectively. The multiplicity of theses signals suggested that para position of two one-
proton doublets at δ 7.45 (J = 8.5 Hz) and δ 7.45 (J = 8.6 Hz) due to H-2’’/H-6’’ respectively. 




























The broadband 13C NMR spectrum (acetone-d6, 100 MHz) of (41) showed the resonance of all 
carbons present in this compound. The 13C-APT-NMR was also recorded and it indicated the 
presence of two methyl, eight methine, and ten quaternary carbons in it. Complete 1H and 13C-
NMR chemical shift assignments of are shown in Table 2.9.   
 
Table 2-9 1H and 13C NMR spectroscopic data for (41) and 1H/13C one-bond shift 
Correlations. 
         Position                    δH (J in Hz)                     δC (multiplicity†) 
 
1 - - 
2                 - 159.5 (-C-) 
3 6.29,s 104.3 (-CH-) 
4 - 180.9 (-C=O-) 
5 - 157.3 (-OH-) 
6 8.05,s 94.8 (-CH-) 
7 - 157.4 (-CH-) 
8 - 106.0 (-CH-) 
9 - 153.3 (-C-) 
10 - 105.0 (-C-) 
1’ - - 
2’ - 77.9 (-C-) 
3’ 6.65,d (10.1) 128.3 (-CH-) 
4’ 5.70,d (10.1) 115.6 (-CH-) 
 5’               1.24,s    27.6 (-CH3-) 
6’ 1.24,s 27.6 (-CH3-) 
1’’ - 122.3 (-C-) 
2’’ 7.45,d (8.5) 130.7(-CH-) 
3’’ 6.44,d (8.6) 115.6 (-CH-) 
4’’ - 157 (-COH-) 
5’’ 6.44,d (8.6) 115.6 (-CH-) 
6’’ 7.45,d (8.5) 130.7 (-CH-) 
 
                  †Multiplicity was determined with the help of 13C-APT and 13C Broad-Band spectra 
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The 1H and 13C-NMR spectroscopic data of compound (41) was similar to those of 
atalantoflavone, reported in literature [15]. This compound was previously reported from 
Erythrina sigmoidea [14]. These spectroscopic data led us to identify compound (41) as 


















 2.3 Antimicrobial activity of crude extract and pure compounds (39-40 and 41) 
    The antimicrobial activity of the methanolic crude extract was examined by using Kirby-Bauer 
disc methods. The methanolic crude extract was screened against four pathogenic bacteria 
namely Gram-positive bacteria (Staphylococcus aureus and Streptococcus agalactiae) and 
Gram-negative bacteria (Escherichia coli and Pseudomonas aeruginosa), all of which were 
organisms provided by Dr. Paul Holloway from the Department of Biology at the University of 
Winnipeg. A negative control was prepared by loading a disc of methanol and ciprofloxacin was 
used as positive control standard. The sample was prepared with moderate concentration 300-
mg/10 ml methanol (30 mg/ml) at 50 µl, 100 µl, 150 µl and 500 µl with 1.500 µg, 3.000 µg, 
4.500 µg, and 15.000 µg Concentrations respectively based on available literature that used high 
concentrations [16] showed in Table 2.10. The disc was left over night for the solvent to dry 
completely in order to rule out the possibility of biological activity due to the solvent. These 
plates were incubated for 24 hours at 37 °C and the crude extract exhibited significant 
antimicrobial activity against Staphylococcus aureus. The zone of inhibition around the disc was 
8 mm that was measured by subtracting the diameter of the disc (6 mm) from the total diameter. 
When the crude was investigated against Staphylococcus aureus, a zone of inhibition of 2 mm 








     The purified known compound curcumin (39) was also tested against Escherichia coli and 
Staphylococcus aureus by following the above stated methodology. The sample was prepared 
with 1 mg/3 ml methanol with the growth medium TSA at a volume of 25 µL at 0.0083 µg 
concentrations respectively, shown in Table 2.11. This compound was inactive while the 
purified compounds sclareolide (40) and atalantoflavone (41), at similar concentration and were 
also tested against Escherichia coli and Staphylococcus aureus and showed no inhibition (figure 
4). All these compounds had the methanol used as a negative control while the positive control 














Figure 4: The Figures shows the discs deposited on agar plate inoculated with test organisms 








Table 2-10: Zone of inhibition (mm) of the crude extract 
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                                                               CHAPTER 3 
 
                                                                Conclusion 
 
 
     The overall goal of this project was to perform phytochemical studies Curcuma longa in order 
to isolate natural products and to evaluate them for antimicrobial activities. This study afforded 
three known compounds: curcumin (39), sclareolide (40), and atalantoflavone (41). These three 
pure compounds did not show antimicrobial activity against Escherichia coli and Staphylococcus 
aureus.  
    The antimicrobial data suggested that these compounds need to be re-evaluated for 
antimicrobial activity at higher concentrations.  During these studies, a number of minor 
metabolites were isolated in trace quantities and we were unable to perform NMR spectroscopic 
studies on them. There is also a possibility that minor metabolites might be responsible for 
antimicrobial activity of this plant.  This problem can be overcome by re-isolation of minor 
metabolites from C. longa using large-scale plant material. Due to COVID-19 pandemic and 
time limitation, we were unable to perform these experiments.   
   Though the proposed objective of this research for the identification of antimicrobial natural 
products was not achieved, these studies resulted in the identification of sclareolide (40) and 
atalantoflavone (41) as major metabolites for the first time from this plant. There is no report 





  Curcumin (39) and other curcuminoids possess the main phytochemicals of Curcuma longa L.  
Curcuma phytochemicals have received much attention due to their diverse biological effects 
[21]. Many publications have recorded broad-spectrum antimicrobial activity and it’s safety for 
use at high doses (12 g/day) in the clinic. The best potential of curcumin is restricted due to the 
low oral bioavailability and lack of solubility in aqueous solvents causing low absorption, quick 
metabolism, and fast systemic elimination. There is a study to improve the stability and solubility 
of curcumin, which was a microencapsulation method that was examined. The microcapsule of 
curcumin with improved solubility is useful as a preservative and colorant in food manufactur 
and it showed strong antimicrobial activity against foodborne pathogens including E. coli and S. 
aureus [17]. 
   Further research on curcumin (39), sclareolide (40), and atalantoflavone (41) could investigate 
its antibiotic potential against rapidly developing bacterial resistance. Other methods to evaluate 
the antimicrobial activity of curcumin include screening with bioassays in the lab such as disk-
diffusion, well diffusion, and broth or agar microdilution. [22].  
  Other various laboratory procedures can be applied to evaluate or screen the in vitro 
antimicrobial activity of these three known compounds such as applying two differentially 
permeable fluorescent probes, namely, propidium iodide and calcein. They provide information 
on the integrity of the bacterial membrane and cellular viability. Propidium iodide interacts with 
deoxyribonucleic acid bases (DNA), fluorescence is produced as a result of this.  Only after the 
bacterial cell membrane has been permeabilized by an agent will propidium iodide enter and 
bind to DNA. When the membrane is damaged, calcein can leak out of the cells [18].  Both the 
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membrane permeabilization assays can confirm membrane leakage in Gram-negative and Gram-
positive bacteria on exposure to the pure compounds. Scanning electron microscopy and 
fluorescence microscopy can also be applied to determine membrane disturbances in bacterial 
cells on exposure to the pure compounds [17]. 
 A survival curve can be used to quantify the antimicrobial effect of curcumin. Test bacterial 
cells are grown in a broth until mid logarithmic phase. Different concentrations of the pure 
compound can be added to the mid logarithmic bacterial cells. After a time, the cells are plated 
out on media plates and colonies counted to determine bacterial survival [18].  
Another suggestion for further research into the antimicrobial activity of curcumin is the use of 
the broth microdilution method to determine the minimum inhibitory concentrations (MICs) and 
the minimum bactericidal concentrations (MBCs) of the compounds. Atalantoflavone (41) was 
reported in the study and it was tested Gram-negative multi-drug resistant phenotypes using the 
broth microdilution method [19].  
   Another suggestion for future research is to determine a relationship between the chemical 
structure of the compound and its biological activity in order to determine the chemical group 
responsible for evoking a biological influence in the organism. For example, natural product 
hedychilactone A was synthesized from sclareolide by an efficient route. Two of the synthetic 
intermediates, α, β-unsaturated ketone and α, β-unsaturated ketone showed strong growth 
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            A5: 13C-NMR spectrum of compound (39) in acetone-d6. 
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A-8: 1H-NMR spectrum of compound (40) in acetone-d6	
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             A-9: 1 3C-APT spectrum of compound (40) in acetone-d6	
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A-10: IG spectrum of compound (40) in acetone-d6	
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A-12: 1H-NMR spectrum of compound (41) in acetone-d6 
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       A-13: 13C-APT spectrum of compound (41) in acetone-d6 
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